Southeast Asian health officials to meet in New Delhi to examine HIV/AIDS, other health issues

NewsGuard 100/100 Score

Health ministers and other officials from 11 Southeast Asian countries will meet on Monday in New Delhi for the World Health Organization's 61st Session of the Regional Committee for Southeast Asia, IANS/New Kerala reports.

During the meeting, officials will examine HIV/AIDS issues in the region, as well as other health topics.

An estimated 3.6 million people in Southeast Asia are living with HIV/AIDS, and approximately 260,000 new HIV cases and 300,000 AIDS-related deaths occurred in the region in 2007. Countries taking part in the meeting are Bangladesh, Bhutan, East Timor, India, Indonesia, Maldives, Myanmar, Nepal, North Korea, Sri Lanka and Thailand.

According to IANS/New Kerala, the groups most affected by HIV/AIDS in the region are commercial sex workers and their clients, injection drug users and men who have sex with men. Other issues expected to be examined at the meeting are universal access to primary health care, vector-borne diseases such as malaria, maternal and infant mortality, and tobacco use. Officials such as WHO Regional Director Samlee Pilanbangchang and Indian Health Minister Anbumani Ramadoss are scheduled to attend the meeting (IANS/New Kerala, 9/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication